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The purpose of this study was to compare the optic disc parameters, retinal nerve fiber (RNFL), and macular ganglion cell layers
between patients with diabetes mellitus (DM) type 2 and healthy controls.
In this cross-sectional study, 69 eyes of 69 diabetic patients without diabetic retinopathy and 47 eyes of 47 healthy controls were
included. Optic disc parameters (i.e., rim area, disc area, cup to disc ratio, cup volume), RNFL, and macular ganglion cell-inner
plexiform layers (GCL+ IPL) thickness were measured by means of spectral domain optical coherence tomography.
There were not statistically significant differences between the diabetic patients and healthy controls in terms of RNFL thickness
(P= .32), rim area (P= .20), disc area (P= .16), cup volume (P= .12), and average macular GCL+ IPL thickness (P= .11).
Nevertheless, binocular RNFL thickness symmetry percentage (P=.03), average cup to disc ratio (P= .02), and superior-nasal
macular GCL+ IPL thickness (P= .04) were statistically significantly different in the diabetic and control groups.
Diabetic patients without retinopathy have more binocular RNFL thickness asymmetry, higher cup to disc ratio, and thinner
sectoral macular GCL+ IPL when compared to healthy controls. Our results may support the statement that DM causes inner retinal
neurodegenerative changes.
Abbreviations: DM = Diabetes Mellitus, FFA = Fundus Fluorescein Angiography, GCL+IPL = Macular Ganglion Cell - Inner
Plexiform Layers, IOP = Intra-ocular Pressure, logMAR = Logarithm of the Minimum Angle of Resolution, RNFL = Retinal Nerve Fiber
Layer, SD-OCT = Spectral Domain Optical Coherence Tomography, SPSS = Statistical Package for the Social Sciences.
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Diabetes mellitus (DM) has become one of the most significant
public health problems in the last decades. As the prevalence of
DM and life expectancy increase worldwide, diabetic complica-
tions also increase.[1] Early detection of ocular complications of
DM is important for the preservation of useful visual acuity.[2]
Retinopathy is the major vision-threatening ocular effect of DM.
In the early stages of diabetic retinopathy, structural neurode-
generative changes such as loss of ganglion cell bodies and
reduction in thickness of the inner retinal layers have been
documented, besides microvascular changes.[3]
The invention of optical coherence tomography (OCT) has
allowed imaging and measuring various aspects of retina and
optic disc.[4] The high resolution of spectral domain OCT (SD-
OCT) allows measurement of the thickness of all individualEditor: Weina Chen.
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retinal layers, including retinal nerve fiber layer (RNFL) and
ganglion cell layer (GCL).[5] In addition, the SD-OCT provides
data related to optic disc. Recent studies, which used SD-OCT for
assessing diabetic ocular effects, have shown that DMmay reduce
GCL+IPL and RNFL thicknesses in the early stages of the
disease.[6] Also, it was reported that DM may affect structural
and biomechanical properties of the optic nerve head.[7,8]
The main potential clinical implication of the present work is
that DM may affect the retinal and optic disc parameters related
to glaucoma, and this condition may cause some problems in
detecting glaucomatous damage in diabetic patients. Although
several studies have been published related to early-onset impact
of DM on RNFL thickness, macular GCL thickness, and optic
disc parameters, yet it is not possible to draw definitive
conclusions about the effects of DM on the inner retina. In the
present study, we sought to extend the observations on the
comparison of optic disc parameters, retinal nerve fiber, and
macular ganglion cell layers between diabetic patients without
retinopathy and healthy controls. By doing so, we tried to
evaluate the early neurodegenerative effects of DM on inner
retinal structures and optic disc. In addition, we evaluated the
associations between HbA1c, diabetes duration, and the studied
ocular parameters. Different from the previous reports, we
examined binocular RNFL thickness asymmetry as a novel
parameter for inner retinal damage.2. Materials and methods
Sixty-nine participants with DM type 2 and 47 healthy controls
who recruited during 2016 were included in this cross-sectional
and comparative study. The present study was conducted in
accordance with the ethical standards of the Declaration of
Pekel et al. Medicine (2017) 96:29 MedicineHelsinki and approved by the local institutional review board
(Pamukkale University Ethics Committee).2.1. Study population
The participants in both the study (i.e., diabetic patients) and
control groups were recruited during the same period. To prevent
potential bias originated from sampling methods, all of the
“consecutively referred” patients to our clinic, who fulfilled the
inclusion criteria, were recruited for the study. All of the
participants in the study group had been diagnosed with DM type
2. The diabetic participants showed no signs of diabetic
retinopathy bilaterally. None of the subjects exhibited any
ocular pathology other than low-grade age-related cataract or
was taking ocular medication at the time of the study. Subjects
with any history of ocular surgery, or intravitreal injection, or
laser photocoagulation, or with ametropia of >2 diopters
spherical equivalent, or with systemic disease such as arterial
hypertension that could affect retinal and optic disc parameters
were excluded. Participants who had poor-quality SD-OCT
images were also excluded. Patients with diabetic major organ
complications (i.e., disorders of heart, blood vessels, nerves,
kidney, etc.) were excluded. The treatment for diabetic group
included only diet in 3 patients, oral antidiabetic medications in
57 patients, and insulin in 9 patients.Table 12.2. Ocular examinations
One eye of each participant, right eyes, was included for the
study. All subjects underwent an ophthalmic examination
including visual acuity assessment, biomicroscopic assessment,
air-puff tonometry measurement, retinal examination, and
measurement with the SD-OCT (Zeiss Cirrus HD 5000 model,
Carl Zeiss Meditec, Dublin, CA). The best corrected visual acuity
was converted to the logarithm of the minimum angle of
resolution (logMAR) equivalent for the statistical analysis. The
Cirrus HD-OCT 5000 has an A scan velocity of 27000scans/sec
with a 5mm axial resolution and a scanning depth of 2mm. The
device uses a light of 840nmwavelength and scans an area of 6
6mm for both macula and optic disc measurements. The SD-
OCT was used to measure optic disc parameters, RNFL
thickness, and macular GCL+IPL thickness. For optic disc
measurements, disc area, rim area, cup volume, average cup to
disc ratio, vertical cup to disc ratio, average RNFL thickness,
RNFL thickness in the 4 quadrants (i.e., inferior, superior, nasal,
and temporal), and binocular RNFL symmetry percentage were
used. RNFL symmetry percentage is defined as the degree of a
RNFL thickness similarity between symmetrically opposed
interocular peripapillary areas. For macular measurements,
average GCL+IPL thickness, minimum GCL+IPL thickness,
and GCL+IPL thickness in the 6 sectors (i.e., inferior, inferior-
nasal, inferior-temporal, superior, superior-nasal, superior-
temporal) were used.Some of the characteristics of the participants are shown.
Diabetic group Control group P
Mean age, y 56.8±8.8 56.2±6.4 .71
Sex (M/F) 29M, 40 F 20M, 27 F .96
SE, diopters 0.17±0.79 0.41±0.74 .11
Visual acuity (logMAR) 0.011±0.032 0.004±0.020 .17
F= female, logMAR= logarithm of the minimum angle of resolution, M=male, SE= spherical
equivalent of refractive error.2.3. Statistical analysis
The Statistical Package for the Social Sciences version 17.0 (SPSS
Inc, Chicago, IL) was used to analyze outcomes. Any “P” values
<.05 were accepted as statistically significant, and all data are
expressed as “mean± standard deviation”. An independent
samples t test was used to compare the studied ocular measure-
ments between the study and control groups. When the Levene
test P values were>.05 for the studied variables, the independent2
samples t test was used. In cases in which assumptions for
parametric t tests were violated, Mann-Whitney U test was used
instead. Categorical variables were compared with the x2 test.
The Pearson correlation analysis was used to examine the
relationships among HbA1c, diabetes duration, and ocular
measurements. The Bonferroni correction was applied to
eliminate type 1 error because of multiple comparisons.
The primary outcome of the present study was the results of
comparison of inner retinal thickness values and optic disc
parameters between the diabetic and healthy eyes. The secondary
outcomes were the correlations of HbA1c levels and diabetes
duration with the various studied ocular parameters in the
diabetic eyes.3. Results
The age range of the participants in the diabetic group was from
42 to 75 years, whereas the age range of the controls was from 42
to 71 years. Some of the demographic and clinical characteristics
of the participants are shown in Table 1. The mean intraocular
pressure (IOP) was 16.5±3.2mmHg in the diabetic group,
whereas it was 16.6±3.2mmHg in the control group (P= .93).
The mean peripapillary RNFL thickness was 95.1±8.0mm in
the diabetic group and 96.5±6.6mm in the control group
(P= .32). Segmental peripapillary RNFL thickness (inferior,
superior, nasal, and temporal) measurements are shown in
Table 2. There were no statistically significant differences in the
quadrantal thickness values between the diabetic and control
groups. The percentage of binocular RNFL thickness symmetry
was 83.7±9.6 in the diabetic group, whereas it was 87.3±7.1 in
the control group (P= .03).
The optic disc parameters including rim area, disc area, average
cup to disc ratio, vertical cup to disc ratio, and cup volume in the
diabetic subjects and healthy controls are shown in Table 3. Rim
area, disc area, and cup volume were similar in the diabetic and
control groups, whereas average and vertical cup to disc ratios
were statistically significantly higher in the diabetic eyes. When
the Bonferroni correction (a/n; 0.05/5) was made, the only
statistically significant result was the high vertical cup-to-disc
ratio in the diabetic eyes.
The mean “average”GCL+IPL thickness was 82.2±6.1mm in
the diabetic eyes and 83.9±4.7mm in the controls (P= .11). The
mean “minimum” GCL+IPL thickness was 78.5±7.2mm in the
diabetic group and 81.0±5.0mm in the control group (P= .04).
The sectoral macular GCL+IPL thickness values in the diabetic
and control groups are demonstrated in Table 4. The sectoral
thickness values of GCL+IPL in the diabetic eyes were thinner
than that of the controls, but this difference was statistically
significant only in the superior-nasal area.
The mean HbA1c value was 7.7±1.9 (range: 4.9–12.5) in the
diabetic group. The mean DM duration was 7.5±5.2 (range:
1–20) years. The correlations of HbA1c levels and diabetes
Table 4
Sectoral macular GCL+IPL thickness (inferior, inferior-nasal,
inferior-temporal, superior, superior-nasal, and superior-tem-
poral) values in the diabetic and control groups are demonstrated.
Diabetic group Control group P
Inferior, mm 81.4±6.6 83.0±4.8 .17
Inferior-nasal, mm 82.3±7.0 84.3±6.0 .11
Inferior-temporal, mm 82.9±6.4 84.1±4.6 .27
Superior, mm 82.8±6.8 84.8±5.2 .09
Superior-nasal, mm 82.7±7.4 85.3±5.7 .04
Superior-temporal, mm 81.0±6.3 81.7±4.9 .52
GCL=ganglion cell layer, IPL= inner plexiform layer.
Table 2
Segmental peripapillary RNFL thickness (inferior, superior, nasal,
and temporal) values in the diabetic and control groups are
demonstrated.
Diabetic group Control group P
Inferior quadrant, mm 125.6±15.4 127.8±11.5 .40
Superior quadrant, mm 115.8±13.5 119.7±14.7 .14
Nasal quadrant, mm 73.0±10.1 73.5±9.1 .79
Temporal quadrant, mm 66.1±8.9 64.4±9.3 .32
RNFL= retinal nerve fiber layer.
Pekel et al. Medicine (2017) 96:29 www.md-journal.comduration with the various studied ocular parameters in the
diabetic eyes are shown in Table 5. There were no significant
correlations between the HbA1c levels and the IOP, RNFL, GCL
+IPL, and optic disc parameters. Diabetes duration was
statistically significantly correlated only with binocular RNFL
symmetry percentage.Table 5
The correlations of HbA1c levels and diabetes duration with the
various studied ocular parameters in the diabetic eyes are shown.
HbA1c Diabetes duration
r P R P4. Discussion
The outcomes of the present study show that diabetic patients
without any signs of ocular involvement have more binocular
RNFL thickness asymmetry, higher cup to disc ratio and thinner
macular GCL+IPL when compared to healthy controls. Since
early detection of diabetic ocular complications is utmost
important to maintain a useful vision, the thinning of the inner
retinal layers such as RNFL, GCL, and IPL may indicate initial
damage of DM on the posterior pole before the appearance of
obvious retinal findings.
In the present study, higher percentage of binocular RNFL
asymmetry found in diabetic eyes may support the emergence of
early neuronal alterations in DM. Also, it was reported that an
interocular difference of the mean peripapillary RNFL thickness
might indicate an early glaucomatous damage.[9] According to
us, binocular RNFL symmetry percentage may help the clinicians
to assess the effects of diabetes duration on the inner retina, since
we found that diabetes duration was correlated with the
binocular RNFL thickness asymmetry. As a novel contribution
to the literature, this study may show the relation between RNFL
thickness symmetry and DM.
In a recent study, it was reported that GCL+IPL and RNFL
thickness values were markedly reduced in diabetic eyes without
retinopathy and the authors concluded that neuroretinal
alterations may precede microvascular abnormalities in DM.[6]
Takis et al[10] showed that the mean inferior sectoral RNFL
thickness was significantly lower in diabetic patients with no or
mild retinopathy compared to that of healthy eyes. There is an
increasing evidence that DM can cause alterations in neural
retina, including loss of ganglion cells.[11–13] In our study, theTable 3
Optic disc parameters taken by SD-OCT in the diabetic and control
groups are shown.
Diabetic group Control group P
Rim area, mm2 1.42±0.23 1.49±0.29 .20
Disc area. mm2 1.94±0.32 1.86±0.25 .16
c/d Average 0.48±0.16 0.39±0.18 .02
c/d Vertical 0.46±0.15 0.38±0.17 .01
Cup volume, mm3 0.13±0.12 0.09±0.11 .12
c/d= cup to disc ratio, SD-OCT= spectral domain optical coherence tomography.
3
macular GCL+IPL thickness was reduced in several sectors in the
diabetic eyes and those outcomes were concordant with the
outcomes of the previous studies.
Optic disc may be affected in DM in several aspects.[7,14] Terai
et al[7] reported that DM affected biomechanical properties of
optic disc in an animal model. Elgin et al[15] demonstrated that
non-glaucomatous eyes of children with type 1 DM and healthy
controls have similar topographic optic nerve head findings. In a
large population-based study, it was reported that neuroretinal
rim area is not associated with a known diagnosis of DM.[16] In
this study, we have found that average and vertical c/d ratios were
higher in diabetic eyes without retinopathy compared to the
controls. Although it may be incidental, this outcome may be
occurred due to the larger disc area and smaller rim area
measured in the diabetic group. Those findings may indicate a
relative predisposition of diabetic eyes to glaucomatous optic disc
damage in long-term follow-up, but in contrary to that statement,
average RNFL thickness was found to be similar in both the
diabetic and control eyes.
In our study, HbA1c and DM duration were not associated
with any of the studied ocular parameters, except for a moderate
correlation between binocular RNFL symmetry percentage and
DM duration. It was reported that macular thickness is inversely
correlated with longer duration of diabetes and HbA1c levels.[17]
However, Srinivasan et al[18] reported that HbA1c and diabetes
duration were not related with retinal tissue thickness. Sugimoto
et al[19] found that glycemic control (i.e., HbA1c levels) affects
RNFLwithin 4 months. Sahin et al[20] showed that there is a mild
negative correlation between HbA1c and average RNFL
thickness, and concluded that thinning of RNFL might beIOP 0.003 0.98 0.13 .31
RNFL average 0.03 0.79 0.04 .75
RNFL symmetry 0.10 0.42 0.25 .04
Rim area 0.06 0.63 0.12 .32
Disc area 0.06 0.61 0.05 .69
c/d Average 0.10 0.42 0.17 .17
c/d Vertical 0.17 0.18 0.15 .21
Cup volume 0.09 0.46 0.02 .86
GCL+ IPL average 0.03 0.82 0.13 .28
GCL+ IPL minimum 0.001 0.99 0.15 .23
c/d= cup to disc ratio, GCL=ganglion cell layer, IOP= intraocular pressure, IPL= inner plexiform
layer, RNFL= retinal nerve fiber layer.
[2] Chen Y, Li J, Yan Y, et al. Diabetic macular morphology changes may
Pekel et al. Medicine (2017) 96:29 Medicinerelated with increased rates of atherosclerosis in patients with
type 2 DM.
One of the main clinical implications of the present study is the
finding that the diabetic eyes without apparent retinopathy may
have subtle inner retinal pathology. It may be suggested that
clinicians should use more sophisticated ocular diagnostic tools
to detect early diabetic retinal abnormalities, in addition to
performing standard slit-lamp biomicroscopy examination with
a 78-diopter or 90-diopter lens. During routine clinical
ophthalmology practice, it would be helpful to remember that
DM may cause inner retinal and optic disc alterations similar to
glaucoma.
Our study has several limitations. First, the present study did
not include patients with diabetic retinopathy. Because OCT
measurement quality might be low in advanced diabetic
retinopathy because of exudates and hemorrhages. Second, we
did not have fundus fluorescein angiography (FFA), which might
show the earliest retinopathy findings that could not be noticed
by routine retinal examination. But there were no clear clinical
indications for FFA in our cases. Lastly, it would be nice if we had
OCT angiography examinations. In the present study, we used
Zeiss Cirrus HD-OCT 5000. Brautaset et al[21] reported that the
repeatability of this device is high in both macula and optic disc
measurements because of its automatic tracking function.
According to us, one of the major strengths of the present study
was the demonstration of higher binocular RNFL thickness
asymmetry in diabetic eyes compared to healthy eyes, which
might indicate early inner retinal neurodegenerative process in
DM without retinopathy.
In conclusion, diabetic eyes and healthy controls have similar
RNFL thickness, rim area, disc area, cup volume, and average
GCL+IPL thickness. Nevertheless, diabetic eyes have higher
percentage of binocular RNFL asymmetry, higher average and
vertical c/d ratios, thinner minimum and superonasal GCL+IPL
thickness. As the examination techniques used in the present
study are specific to glaucoma diagnosis, our findings may
indicate a relative predisposition of diabetic eyes to glaucomatous
retinal damage. In addition, we should speculate that DM may
make difficult to detect pure glaucomatous posterior pole
damage. In further longitudinal studies, the study group may
be extended to cover diabetic patients in various stages of diabetic
retinopathy.References
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